Scientific article

Hémostase. Aspirine: une ou deux fois par jour?

Published inRevue médicale suisse, vol. 10, no. 412-413, p. 53-56
Publication date2014

Aspirin is a cornerstone in the prevention of ischemic events and guidelines usually recommend a once-daily dosing. This dosing is based at least in part on the platelet renewal rate, which is of only 10-15% a day. A once-daily dosing is now challenged by several studies demonstrating that when platelet turnover is increased, such as in patients with diabetes or essential thrombocytemia, the inhibition of platelet function provided by aspirin is no longer homogeneous between dosing with a significant recovery of platelet function within a day that is blunted by a twice-daily dosing. This review addresses the issue of aspirin dosing in selected patients in the controversial era of personalized antiplatelet therapy.

Citation (ISO format)
FONTANA, Pierre et al. Hémostase. Aspirine: une ou deux fois par jour? In: Revue médicale suisse, 2014, vol. 10, n° 412-413, p. 53–56.
Main files (1)
Article (Published version)
ISSN of the journal1660-9379

Technical informations

Creation03/14/2014 3:20:00 PM
First validation03/14/2014 3:20:00 PM
Update time03/14/2023 9:01:35 PM
Status update03/14/2023 9:01:35 PM
Last indexation01/16/2024 9:24:50 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack